Gender, Bladder Cancer Healthcare and Burden of COVID-19

Abstract

Bladder cancer as one of the main comorbid diseases might be more susceptible to develop COVID-19 infection with a higher mortality risk during the COVID-19 pandemic. The European Association of Urology (EAU) recommended a comprehensive panel for bladder cancer diagnosis and treatment during this global health problem. The urgent need for treatments of COVID-19 during the pandemic has persuaded researchers to evaluate the different medications, which may lead to drug shortages. Therefore, in this review paper, we have focused on the least recommendations of EAU about bladder cancer during of COVID-19 pandemic to provide a comprehensive panel for high-risk patients.

Keywords:

• COVID-19
• SARS-CoV-2
• bladder cancer
• Bacillus Calmette-Guérin (BCG)
• risk factor

Acknowledgments

The authors are thankful for the colleagues who provided suggestions regarding this manuscript.

Disclosure statement

No potential conflict of interest was reported by the author(s).